Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease?

Table 1 Demographic information, n (%)

Variables	Invasive mechanical ventilation	Non-invasive mechanical ventilation	No mechanical ventilation	Total	P valuea	P valueb
Age > 60 yr	24	25	62	111	1.00	1.00
	92.3	96.2	93.9	94.1
Male sex	18	12	26	56	0.01	0.55
	69.2	46.2	39.4	47.5
Vaccinated against COVID-19	2	7	16	25	0.13	0.16
	7.7	26.9	24.2	21.2
Hypertension	25	21	59	105	0.43	0.31
	96.2	80.8	89.4	89.0
Diabetes mellitus	15	13	33	61	0.51	1.00
	57.7	50.0	50.0	51.7
Chronic liver disease	0	1	1	2	1.00	0.49
	0.0	3.8	1.5	1.7
Chronic obstructive pulmonary disease	8	11	13	32	0.26	0.26
	30.8	42.3	19.7	27.1
Coronary artery disease	11	8	21	40	0.34	0.92
	42.3	30.8	31.8	33.9
Congestive heart failure	10	11	17	38	0.23	0.12
	38.5	42.3	25.8	32.2
Remdesivir	12	16	32	60	0.84	0.26
	46.2	61.5	48.5	50.8
Steroids	24	22	44	90	0.01	0.12
	92.3	84.6	66.7	76.3

^aChi square test between non mechanical ventilation and non invasive mechanical ventilation.

^bChi square test between non mechanical ventilation and invasive mechanical ventilation. COVID-19: Coronavirus disease 2019.